George Soros Bought This Under-the-Radar Biotech Stock: Should You?
The Soros Fund Management picked up a healthy stake in the rare disease and cancer drugmaker Aeglea BioTherapeutics in the second quarter.
Monday, August 20, 2018
George Soros Bought This Under-the-Radar Biotech Stock: Should You?
George Soros Bought This Under-the-Radar Biotech Stock: Should You?
The Soros Fund Management picked up a healthy stake in the rare disease and cancer drugmaker Aeglea BioTherapeutics in the second quarter.
Related Posts:
0 comments:
Post a Comment